Month: January 2025

HOUSTON, Jan. 22, 2025 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a global leader in carbon-based thermal management and battery safety solutions, has announced an innovative collaboration with the prestigious Scripps Research Institute’s Baran Lab. Together, the teams have developed a groundbreaking pyrolytic carbon (PC) electrode material, poised to transform synthetic organic electrochemistry. The jointly developed electrode is a low-cost, robust, and versatile alternative to traditional amorphous carbon materials such as reticulated vitreous carbon (RVC) and glassy carbon (GC). With unparalleled mechanical strength and reactivity comparable to RVC and GC, this novel PC material overcomes the limitations of cost and scalability that have historically...

President Trump’s announcement of historic investment into AI fuels AI innovation, helping to pave the way for Rezolve Ai’s expansion and leadership in intelligent retail solutions NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a trailblazer in AI-powered retail transformation, celebrates the announcement by President Trump of the creation of Stargate involving a $500 billion commitment to artificial intelligence, as a pivotal moment for the industry. This unprecedented commitment to invest is set to accelerate AI adoption across sectors helping to reinforce Rezolve Ai’s strategic position to redefine the $30 trillion retail market with cutting-edge solutions such as Brain Commerce and Brain Checkout. Rezolve Ai believes it is uniquely positioned to capitalize on this AI boom through its established...

January 22, 2025 Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announced today the appointment of Dr Gary A. Shangold as Chief Medical Officer with immediate effect. Commenting, Stephen Stamp, CEO and CFO of Biodexa said: “I am delighted to welcome Gary to the team. As Biodexa moves towards the later clinical stages including an upcoming global Phase 3 registrational study in FAP, it is essential we access specialists with Gary’s knowledge and experience. I have worked with Gary before at Xanodyne where he was instrumental in securing two NDAs”. Dr Shangold has extensive experience...

PITTSBURGH, Jan. 22, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR) (the “Company”), a global leader in materials, networking, and lasers, announced today that it will release second-quarter fiscal 2025 financial results on Wednesday, February 5, after the New York Stock Exchange closes. The release will be followed by a live audio webcast at 5:00 p.m. ET to discuss the results. The Company invites investors to join the live audio webcast at coherent.com/company/ investor-relations/financial-webcasts. The webcast will be recorded, and a replay will be available within 24 hours after the live audio webcast on the company’s website. Media Contact: Amy Wilsoncorporate.communications@coherent.com

SARASOTA, FL, Jan. 22, 2025 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the filing of a provisional patent application with the U.S. Patent and Trademark Office (USPTO). This application, focused on its lead asset SPC-15, highlights Silo’s commitment to advancing treatments for stress-induced psychiatric disorders, including post-traumatic stress disorder (PTSD). The provisional patent covers the chronic, combinatorial targeting of N-methyl-D-aspartate receptors (NMDARs) and serotonin type IV receptors (5-HT4Rs) to extend behavioral effects against stress-induced perseverative behavior and hyponeophagia. This filing adds to Silo’s growing portfolio of pending patents for SPC-15...

LOS ANGELES, Jan. 22, 2025 (GLOBE NEWSWIRE) — AI Unlimited Group Inc. (OTCQB: AIUG) is pleased to announce the strategic rebranding of its subsidiary, BeyondTrade Securities Inc., to Nest Egg Securities, Inc. This transformation represents a significant step forward in the company’s progression into the brokerage and self-directed investment landscape, underscoring its commitment to equipping individuals with sophisticated, accessible tools to secure long-term financial stability. A Reimagined Identity for an Evolving Mission The rebranding to Nest Egg Securities underscores the company’s dedication to delivering seamless, innovative investment solutions. With the forthcoming launch of the Nest Egg Investments application, the platform will cater to millennials and individuals seeking intuitive tools to build IRAs and develop enduring...

CAMARILLO, CA, Jan. 22, 2025 (GLOBE NEWSWIRE) — NEWTON GOLF Company (Nasdaq: SPGC) (“NEWTON GOLF” or the “Company”), a technology-forward golf company with a growing portfolio of golf products, including putters, golf shafts, golf grips, and other golf-related accessories, announces that Greg Campbell, Executive Chairman, will present a corporate overview at the DealFlow Events MicroCap Conference. The conference is being held on January 28 – 30, 2025 at the Borgata Hotel Casino & Spa in Atlantic City, NJ.Event: Deal Flow Events MicroCap ConferencePresentation Date: January 29, 2025Time: 9:30 AM ET   Mr. Campbell will be available for one-on-one meetings with registered investors of the conference. To register for the conference and to schedule a one-on-one meeting, please click here: https://themicrocapconference.com/tickets/. An...

WARSAW, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company gained distribution rights to bring additional bracing solutions to the US market through its OrthoPediatrics Specialty Bracing (OPSB) division. OrthoPediatrics’ OPSB division has established a distribution agreement with Thrive Orthopedics LLC focused on three unique pediatric orthotic solutions. The Thrive Orthopedics F3 Hero Pediatric AFO is a lightweight carbon fiber ankle foot orthosis that provides the stability needed to improve walking while allowing flexibility and energy return at the correct moments to produce a more normalized, smooth, and dynamic walking pattern. This type of AFO is indicated...